This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Congenital muscular dystrophies (CMDs) are a heterogenous group of autosomal recessively inherited muscle disorders. Laminin α2 negative CMD (MDC1A) constitutes approximately 40% of all CMD in the white population. A number of muscular dystrophies with secondary loss of laminin α2 are known, including Fukuyama CMD, MDC1B, MDC1C, and muscle-eye-brain disease. Patients with limb-girdle muscular dystrophy (LGMD 2I) have different mutations in the same gene as MDC1C but have a milder clinical course. Other forms of CMD with normal expression of laminin α2 have been identified at the molecular level, including CMD with rigid spine (RSMD-1) and Ullrich CMD. Despite rapid progress in classification, many patients with a phenotype of CMD do not match to any of the described forms.
Respiratory failure and the need of ventilation have been reported, but no studies have yet systematically addressed the determinants of respiratory muscle weakness.1–4⇓⇓⇓
Methods.
We performed a prospective respiratory assessment of 23 patients with CMD and 4 patients with LGMD 2I from 1998 to 2001. Patients had a full diagnostic workup including muscle immunohistochemistry and additional molecular studies according to the criteria of the European project of genetic resolution of …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
